News | April 11, 2025
Granules India completes acquisition of Senn Chemicals
Strengthening capabilities in Peptide Therapeutics and CDMO services
Strengthening capabilities in Peptide Therapeutics and CDMO services
The board of directors accepted Hrosz’s resignation and expressed appreciation for his significant contributions during his tenure
Shilpa’s product has been approved as a generic version to the innovator - Chantix Tablets, 0.5 mg and 1 mg, of PF Prism C.V. (PF Prism)
Data highlight ambition to transform prevention and treatment for serious bacterial infections and develop novel preventative strategies for respiratory viral infections
Raichur site is the group’s largest API facility and part of a wider network of seven sites
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
Asahi Kasei Life Science covers a broad range of bioprocess products and services
This investment is in addition to its first multi-billion-dollar project that was awarded to Fluor in 202
Nadda noted that on the basis of economic caste census, 50 crore people were brought under this scheme
Findings likely to generate hypotheses about potential new uses of drugs
Subscribe To Our Newsletter & Stay Updated
